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OBJECTIVE: The goal of my study is 
Ayahuasca, known as one of the most 
hallucinogenic drugs of the world. I have  
focused on its pharmacology and effects.  
METHODS: I have studied this drug by 
consulting different scientific articles.  
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ABSTRACT: Ayahuasca is known as a 
hallucinogenic beverage from extremely potents 
psychoactive plants used by shamans. DMT, 
structurally related to the neurotransmitter 
serotonin (5-HT), binds to its receptors. ß-
carboline alkaloids contribute to the overall 
effects of Ayahuasca by blocking monoamine 
oxidase activity (MAO). That is how it prevents 
DMT degradation. Ayahuasca causes dramatic 
modifications in perception, the sense of self 
and reality and can be very intense but relatively 
short in duration. The drug performs notorious 
cardiovascular, autonomic, neuroendocrine and 
neurological effects. 
 
The quality and the quantity of the brew, the psychosomatic state of the patient, 
the degree of familiarity with the drug and so a bad diet are conditioning factors. 
Our position within time and space, identification of what is real or not, what is 
ours or somebody else’s, the sense of ourselves, discrimination of movements, 
volumes, bodily equilibrium etc., can be altered.  
ENVIRONMENTAL EFFECTS: The 
lighting, odors, posture, sounds, 
etc., are conditions that allow or not 
the consumer to capture stimuli 
which were previously subliminal. 
These conditions can provoke a 
hallucinogenic intoxication. 
INTERFERENCES BETWEEN PARTICIPANTS: During the session, the 
continuity of relationships between consumers decreases, but there 
are some exchanges between all of them called “energies”. The 
eviction of those called “energies” can be at an emotional level, at a 
mental level, or at a physical level.  
INFLUENCE OF THE THERAPIST: The healer is, 
perhaps, the most important conditioning 
factor. The shaman’s role consists of controlling, 
modulating and harmonizing the “energies” of 
each particpant.  
CONDITIONING FACTORS 
MAO-A inhibition by ß-carboline alkaloids 
facilitates DMT absorption by preventing 
its metabolism, so its elimination 
decreases. This action allows the activity 
of DMT when it is taken orally. 
The effects caused by DMT are 
due to the interactions at the 
central serotonin receptors site 
5-HT2A , 5-HT2C  and 5-HT1A . 
ß-carboline alkaloids generally bind to 5-
HT2A and to 5-HT2C. THH inhibits 5-HT 
uptake. 
The increased level of 5-HT compete with 
DMT for the receptors and the metabolism 
of the last mentioned becomes even 
slower. 
MECHANISM OF ACTION PHARMACOKINETICS 
O-demethylation of harmaline: 
cytochromes P450 1A1, 1A2 and 2D6. 
 
O-demethylation of harmine:  
cytochromes CYP1A1, CYP1A2, 
CYP2C9, CYP2C19, and CYP2D6.  
 
Harmine disappears rapid from plasma, but 
there are significant concentrations of THH, 
Harmol and Harmalol. 
 
Major urinary metabolites: harmol sulfate and 
harmol glucoronide.  
 
Rapid disappearance from plasma. 
EFFECTS 
Cardiovascular effects: increases in blood pressure and so in 
heart rate.  
 
Autonomic effects: stimulation of intestinal motility, vomits, 
tremors and increases on rectal temperature and pupil diameter.  
 
Neuroendocrines effects:  increased growth hormone, cortisol, 
corticotrophin and  ß-endorphin levels.  
 
Neurological levels: Alpha-2, delta and beta frequency bands are 
reduced over the temporo-parieto-occipital junction whilst theta 
is decreased in the temporomedial and frontomedial areas. 
 
CONCLUSIONS 
The Ayahuasca brew contains both ß-carboline and tryptamine alkaloids, which are 
necessary for the psychoactive effects of the drug. P.viridis and D.cabrerana are rich 
in DMT and B.caapi in ß-carboline alkaloids.  
DMT has a rapid metabolism by MAO-A, so its interaction with ß-carboline alkaloids, 
which act as MAOi, allows its absorption preventing its rapid elimination.  
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